Funding sources This work was funded by a grant from the Swiss Cancer League to R.E.H. and R.H. (OCS-02262-08-2008).
Clinical and Laboratory Investigations
High expression of FOXP3 in primary melanoma is associated with tumour progression
Version of Record online: 13 JAN 2014
© 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 170, Issue 1, pages 103–109, January 2014
How to Cite
Gerber, A.L., Münst, A., Schlapbach, C., Shafighi, M., Kiermeir, D., Hüsler, R. and Hunger, R.E. (2014), High expression of FOXP3 in primary melanoma is associated with tumour progression. British Journal of Dermatology, 170: 103–109. doi: 10.1111/bjd.12641
Conflicts of interest None declared.
- Issue online: 13 JAN 2014
- Version of Record online: 13 JAN 2014
- Accepted manuscript online: 30 SEP 2013 10:59AM EST
- Manuscript Accepted: 15 SEP 2013
- Swiss Cancer League. Grant Number: OCS-02262-08-2008
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.